Report Detail
Global Type 2 Diabetes Market Research Report 2019
- RnM3126950 |
- 14 March, 2019 |
- Global |
- 90 Pages |
- QYResearch |
- Pharma & Healthcare
Type 2 diabetes is a progressive condition in which the body becomes resistant to the normal effects of insulin and/or gradually loses the capacity to produce enough insulin in the pancreas. We do not know what causes type 2 diabetes. Type 2 diabetes is associated with modifiable lifestyle risk factors. Type 2 diabetes also has strong genetic and family related risk factors.
The dramatic increase in the prevalence, progressive nature and diagnosis of type 2 diabetes is the main driver of this rapid growth rate. The rise in disease-related comorbidities has also fuelled a more aggressive approach to treatment, including the use of multiple-drug therapies.
The Americas dominated the global type 1 diabetes drug market and accounted for close to 50% of the global type 1 diabetes market size. The US was the largest revenue contributor to the diabetes drug market in this region because of the growing prevalence of the disease and rise in obesity. The accessibility to therapies by reimbursement programs is further expected to drive the growth of the diabetes drug market size in the Americas.
The global Type 2 Diabetes market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Type 2 Diabetes volume and value at global level, regional level and company level. From a global perspective, this report represents overall Type 2 Diabetes market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Novo Nordisk
Sanofi
Merck
Eli Lily
AstraZeneca
Astellas Pharma
Daiichi Sankyo
Biocon
Boehringer Ingelheim
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Insulins
DPP-4 Inhibitors
GLP-1 Receptor Agonists
SGLT-2 Inhibitors
Segment by Application
Drugstore
Hospital
Others
Table of Contents
Executive Summary
1 Type 2 Diabetes Market Overview
- 1.1 Product Overview and Scope of Type 2 Diabetes
- 1.2 Type 2 Diabetes Segment by Type
- 1.2.1 Global Type 2 Diabetes Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 Insulins
- 1.2.3 DPP-4 Inhibitors
- 1.2.4 GLP-1 Receptor Agonists
- 1.2.5 SGLT-2 Inhibitors
- 1.3 Type 2 Diabetes Segment by Application
- 1.3.1 Type 2 Diabetes Consumption Comparison by Application (2014-2025)
- 1.3.2 Drugstore
- 1.3.3 Hospital
- 1.3.4 Others
- 1.4 Global Type 2 Diabetes Market by Region
- 1.4.1 Global Type 2 Diabetes Market Size Region
- 1.4.2 North America Status and Prospect (2014-2025)
- 1.4.3 Europe Status and Prospect (2014-2025)
- 1.4.4 China Status and Prospect (2014-2025)
- 1.4.5 Japan Status and Prospect (2014-2025)
- 1.5 Global Type 2 Diabetes Market Size
- 1.5.1 Global Type 2 Diabetes Revenue (2014-2025)
- 1.5.2 Global Type 2 Diabetes Production (2014-2025)
2 Global Type 2 Diabetes Market Competition by Manufacturers
- 2.1 Global Type 2 Diabetes Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Type 2 Diabetes Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Type 2 Diabetes Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Type 2 Diabetes Production Sites, Area Served, Product Types
- 2.5 Type 2 Diabetes Market Competitive Situation and Trends
- 2.5.1 Type 2 Diabetes Market Concentration Rate
- 2.5.2 Type 2 Diabetes Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Type 2 Diabetes Production Market Share by Regions
- 3.1 Global Type 2 Diabetes Production Market Share by Regions
- 3.2 Global Type 2 Diabetes Revenue Market Share by Regions (2014-2019)
- 3.3 Global Type 2 Diabetes Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Type 2 Diabetes Production
- 3.4.1 North America Type 2 Diabetes Production Growth Rate (2014-2019)
- 3.4.2 North America Type 2 Diabetes Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Type 2 Diabetes Production
- 3.5.1 Europe Type 2 Diabetes Production Growth Rate (2014-2019)
- 3.5.2 Europe Type 2 Diabetes Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Type 2 Diabetes Production (2014-2019)
- 3.6.1 China Type 2 Diabetes Production Growth Rate (2014-2019)
- 3.6.2 China Type 2 Diabetes Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Type 2 Diabetes Production (2014-2019)
- 3.7.1 Japan Type 2 Diabetes Production Growth Rate (2014-2019)
- 3.7.2 Japan Type 2 Diabetes Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Type 2 Diabetes Consumption by Regions
- 4.1 Global Type 2 Diabetes Consumption by Regions
- 4.2 North America Type 2 Diabetes Consumption (2014-2019)
- 4.3 Europe Type 2 Diabetes Consumption (2014-2019)
- 4.4 China Type 2 Diabetes Consumption (2014-2019)
- 4.5 Japan Type 2 Diabetes Consumption (2014-2019)
5 Global Type 2 Diabetes Production, Revenue, Price Trend by Type
- 5.1 Global Type 2 Diabetes Production Market Share by Type (2014-2019)
- 5.2 Global Type 2 Diabetes Revenue Market Share by Type (2014-2019)
- 5.3 Global Type 2 Diabetes Price by Type (2014-2019)
- 5.4 Global Type 2 Diabetes Production Growth by Type (2014-2019)
6 Global Type 2 Diabetes Market Analysis by Applications
- 6.1 Global Type 2 Diabetes Consumption Market Share by Application (2014-2019)
- 6.2 Global Type 2 Diabetes Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Type 2 Diabetes Business
- 7.1 Novo Nordisk
- 7.1.1 Novo Nordisk Type 2 Diabetes Production Sites and Area Served
- 7.1.2 Type 2 Diabetes Product Introduction, Application and Specification
- 7.1.3 Novo Nordisk Type 2 Diabetes Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 Sanofi
- 7.2.1 Sanofi Type 2 Diabetes Production Sites and Area Served
- 7.2.2 Type 2 Diabetes Product Introduction, Application and Specification
- 7.2.3 Sanofi Type 2 Diabetes Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 Merck
- 7.3.1 Merck Type 2 Diabetes Production Sites and Area Served
- 7.3.2 Type 2 Diabetes Product Introduction, Application and Specification
- 7.3.3 Merck Type 2 Diabetes Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 Eli Lily
- 7.4.1 Eli Lily Type 2 Diabetes Production Sites and Area Served
- 7.4.2 Type 2 Diabetes Product Introduction, Application and Specification
- 7.4.3 Eli Lily Type 2 Diabetes Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 AstraZeneca
- 7.5.1 AstraZeneca Type 2 Diabetes Production Sites and Area Served
- 7.5.2 Type 2 Diabetes Product Introduction, Application and Specification
- 7.5.3 AstraZeneca Type 2 Diabetes Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
- 7.6 Astellas Pharma
- 7.6.1 Astellas Pharma Type 2 Diabetes Production Sites and Area Served
- 7.6.2 Type 2 Diabetes Product Introduction, Application and Specification
- 7.6.3 Astellas Pharma Type 2 Diabetes Production, Revenue, Price and Gross Margin (2014-2019)
- 7.6.4 Main Business and Markets Served
- 7.7 Daiichi Sankyo
- 7.7.1 Daiichi Sankyo Type 2 Diabetes Production Sites and Area Served
- 7.7.2 Type 2 Diabetes Product Introduction, Application and Specification
- 7.7.3 Daiichi Sankyo Type 2 Diabetes Production, Revenue, Price and Gross Margin (2014-2019)
- 7.7.4 Main Business and Markets Served
- 7.8 Biocon
- 7.8.1 Biocon Type 2 Diabetes Production Sites and Area Served
- 7.8.2 Type 2 Diabetes Product Introduction, Application and Specification
- 7.8.3 Biocon Type 2 Diabetes Production, Revenue, Price and Gross Margin (2014-2019)
- 7.8.4 Main Business and Markets Served
- 7.9 Boehringer Ingelheim
- 7.9.1 Boehringer Ingelheim Type 2 Diabetes Production Sites and Area Served
- 7.9.2 Type 2 Diabetes Product Introduction, Application and Specification
- 7.9.3 Boehringer Ingelheim Type 2 Diabetes Production, Revenue, Price and Gross Margin (2014-2019)
- 7.9.4 Main Business and Markets Served
8 Type 2 Diabetes Manufacturing Cost Analysis
- 8.1 Type 2 Diabetes Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Type 2 Diabetes
- 8.4 Type 2 Diabetes Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Type 2 Diabetes Distributors List
- 9.3 Type 2 Diabetes Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Type 2 Diabetes Market Forecast
- 11.1 Global Type 2 Diabetes Production, Revenue Forecast
- 11.1.1 Global Type 2 Diabetes Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Type 2 Diabetes Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Type 2 Diabetes Price and Trend Forecast (2019-2025)
- 11.2 Global Type 2 Diabetes Production Forecast by Regions (2019-2025)
- 11.2.1 North America Type 2 Diabetes Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Type 2 Diabetes Production, Revenue Forecast (2019-2025)
- 11.2.3 China Type 2 Diabetes Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Type 2 Diabetes Production, Revenue Forecast (2019-2025)
- 11.3 Global Type 2 Diabetes Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Type 2 Diabetes Consumption Forecast (2019-2025)
- 11.3.2 Europe Type 2 Diabetes Consumption Forecast (2019-2025)
- 11.3.3 China Type 2 Diabetes Consumption Forecast (2019-2025)
- 11.3.4 Japan Type 2 Diabetes Consumption Forecast (2019-2025)
- 11.4 Global Type 2 Diabetes Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Type 2 Diabetes Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Type 2 Diabetes . Industry analysis & Market Report on Type 2 Diabetes is a syndicated market report, published as Global Type 2 Diabetes Market Research Report 2019. It is complete Research Study and Industry Analysis of Type 2 Diabetes market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
